Aldeyra Therapeutics Ownership 2024 | Who Owns Aldeyra Therapeutics Now?
Institutional Ownership
59.13%
Insider Ownership
2.45%
Retail Ownership
38.42%
Institutional Holders
104.00
Aldeyra Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 15.61% | 0.73% | 9,275,851 | 682,265 | 7.94% | 30,703,067 | Jun 30, 2024 |
| KNOLL CAPITAL MANAGEMENT, LLC | 9.22% | 12.21% | 5,475,516 | - | - | 18,123,957 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.30% | 0.00% | 3,742,386 | -126,693 | -3.27% | 12,387,298 | Jun 30, 2024 |
| BLACKROCK INC. | 6.10% | 0.00% | 3,621,949 | 311,162 | 9.40% | 11,988,651 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 2.69% | 0.11% | 1,599,673 | 281,518 | 21.36% | 5,294,918 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.92% | 0.00% | 1,138,043 | 109,845 | 10.68% | 3,767,332 | Jun 30, 2024 |
| STATE STREET CORP | 1.61% | 0.00% | 957,720 | 18,151 | 1.93% | 3,170,053,000 | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 1.42% | 0.01% | 841,571 | -126,244 | -13.04% | 2,735,105 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.13% | 0.00% | 672,057 | -210,153 | -23.82% | 2,224,827 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.89% | 0.00% | 531,221 | 531,221 | 100.00% | 1,758,342,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.85% | 0.00% | 503,300 | -224,390 | -30.84% | 1,665,923 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.75% | 0.00% | 445,886 | -6,563 | -1.45% | 1,475,000 | Jun 30, 2024 |
| PFG INVESTMENTS, LLC | 0.67% | 0.09% | 396,247 | 396,247 | 100.00% | 1,311,578 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 0.67% | 0.00% | 395,297 | 7,993 | 2.06% | 1,308,433 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.65% | 0.00% | 385,507 | -3,680 | -0.95% | 1,276,028,000 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.64% | 0.00% | 378,490 | -20,461 | -5.13% | 1,252,803 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.56% | 0.00% | 334,669 | -46,104 | -12.11% | 1,107,754 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.54% | 0.00% | 321,938 | -225,702 | -41.21% | 1,065,615 | Jun 30, 2024 |
| MORGAN STANLEY | 0.52% | 0.00% | 311,404 | -38,142 | -10.91% | 1,030,748 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.51% | 0.00% | 300,352 | 7,965 | 2.72% | 994,165 | Jun 30, 2024 |
Aldeyra Therapeutics's largest institutional shareholder is PERCEPTIVE ADVISORS LLC, holding 15.61% of the company's total share outstanding, currently valued at $30.70M. The top 10 institutional shareholders own together 46.88% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KNOLL CAPITAL MANAGEMENT, LLC | 9.22% | 12.21% | 5,475,516 | - | - | 18,123,957 | Jun 30, 2024 |
| PERCEPTIVE ADVISORS LLC | 15.61% | 0.73% | 9,275,851 | 682,265 | 7.94% | 30,703,067 | Jun 30, 2024 |
| JOHNSON & JOHNSON | 0.50% | 0.25% | 299,669 | - | - | 991,904 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 2.69% | 0.11% | 1,599,673 | 281,518 | 21.36% | 5,294,918 | Jun 30, 2024 |
| PFG INVESTMENTS, LLC | 0.67% | 0.09% | 396,247 | 396,247 | 100.00% | 1,311,578 | Jun 30, 2024 |
| PALO ALTO INVESTORS LP | 0.38% | 0.09% | 225,465 | - | - | 746,289 | Jun 30, 2024 |
| PROVIDENCE WEALTH ADVISORS, LLC | 0.04% | 0.07% | 25,000 | 3,500 | 16.28% | 84,000 | Jun 30, 2024 |
| JOSEPH P. LUCIA & ASSOCIATES, LLC | 0.05% | 0.05% | 28,252 | - | - | 93,514 | Jun 30, 2024 |
| LAIDLAW WEALTH MANAGEMENT LLC | 0.03% | 0.03% | 16,875 | 4,150 | 32.61% | 55,856 | Jun 30, 2024 |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC | 0.10% | 0.02% | 57,800 | -2,500 | -4.15% | 191,318 | Jun 30, 2024 |
| TOBIAS FINANCIAL ADVISORS, INC. | 0.04% | 0.02% | 23,695 | -4,478 | -15.89% | 78,430 | Jun 30, 2024 |
| HENNION & WALSH ASSET MANAGEMENT, INC. | 0.15% | 0.01% | 88,122 | 6,944 | 8.55% | 291,684 | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 1.42% | 0.01% | 841,571 | -126,244 | -13.04% | 2,735,105 | Jun 30, 2024 |
| KING WEALTH | 0.02% | 0.01% | 11,000 | 1,000 | 10.00% | 36,000 | Jun 30, 2024 |
| HIKARI POWER LTD | 0.03% | 0.01% | 20,020 | - | - | 66,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 0.75% | 0.00% | 445,886 | -6,563 | -1.45% | 1,475,000 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.89% | 0.00% | 531,221 | 531,221 | 100.00% | 1,758,342,000 | Jun 30, 2024 |
| VERITION FUND MANAGEMENT LLC | 0.37% | 0.00% | 219,827 | -720,571 | -76.62% | 727,627 | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.56% | 0.00% | 334,669 | -46,104 | -12.11% | 1,107,754 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.03% | 0.00% | 16,020 | -9,229 | -36.55% | 53,000 | Jun 30, 2024 |
The largest Aldeyra Therapeutics shareholder by % of total assets is KNOLL CAPITAL MANAGEMENT, LLC. The company owns 5.48M shares of Aldeyra Therapeutics (ALDX), representing 12.21% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | 15.61% | 0.73% | 9,275,851 | 682,265 | 7.94% | 30,703,067 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.89% | 0.00% | 531,221 | 531,221 | 100.00% | 1,758,342,000 | Jun 30, 2024 |
| PFG INVESTMENTS, LLC | 0.67% | 0.09% | 396,247 | 396,247 | 100.00% | 1,311,578 | Jun 30, 2024 |
| BLACKROCK INC. | 6.10% | 0.00% | 3,621,949 | 311,162 | 9.40% | 11,988,651 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 2.69% | 0.11% | 1,599,673 | 281,518 | 21.36% | 5,294,918 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.92% | 0.00% | 1,138,043 | 109,845 | 10.68% | 3,767,332 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.10% | 0.00% | 60,298 | 60,298 | 100.00% | 199,586 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.09% | 0.00% | 51,458 | 51,458 | 100.00% | 170,326 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.00% | 46,326 | 46,326 | 100.00% | 153,339 | Jun 30, 2024 |
| AMERICAN CENTURY COMPANIES INC | 0.09% | 0.00% | 53,388 | 36,528 | 216.65% | 176,714 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.33% | 0.00% | 195,722 | 34,885 | 21.69% | 647,840 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 26,802 | 26,802 | 100.00% | 88,715 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 24,405 | 24,405 | 100.00% | 80,781 | Jun 30, 2024 |
| STATE STREET CORP | 1.61% | 0.00% | 957,720 | 18,151 | 1.93% | 3,170,053,000 | Jun 30, 2024 |
| STIFEL FINANCIAL CORP | 0.03% | 0.00% | 15,517 | 15,517 | 100.00% | 51,361 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.02% | 0.00% | 14,168 | 14,168 | 100.00% | 46,896 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.18% | 0.00% | 104,927 | 13,210 | 14.40% | 347,309 | Jun 30, 2024 |
| RHUMBLINE ADVISERS | 0.13% | 0.00% | 76,981 | 12,907 | 20.14% | 254,797 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.11% | 0.00% | 62,990 | 12,550 | 24.88% | 208,497 | Jun 30, 2024 |
| DIVERSIFIED TRUST CO | 0.02% | 0.00% | 12,265 | 12,265 | 100.00% | 40,597 | Jun 30, 2024 |
As of Jun 30 2024, Aldeyra Therapeutics's largest institutional buyer is PERCEPTIVE ADVISORS LLC. The company purchased 682.26K stocks of ALDX, valued at $30.70M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| VERITION FUND MANAGEMENT LLC | 0.37% | 0.00% | 219,827 | -720,571 | -76.62% | 727,627 | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.07% | 0.00% | 43,825 | -344,880 | -88.73% | 145,061 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | 0.54% | 0.00% | 321,938 | -225,702 | -41.21% | 1,065,615 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.85% | 0.00% | 503,300 | -224,390 | -30.84% | 1,665,923 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 1.13% | 0.00% | 672,057 | -210,153 | -23.82% | 2,224,827 | Jun 30, 2024 |
| VANGUARD GROUP INC | 6.30% | 0.00% | 3,742,386 | -126,693 | -3.27% | 12,387,298 | Jun 30, 2024 |
| EAGLE ASSET MANAGEMENT INC | 1.42% | 0.01% | 841,571 | -126,244 | -13.04% | 2,735,105 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -126,176 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -107,748 | -100.00% | - | Jun 30, 2024 |
| AQR CAPITAL MANAGEMENT LLC | 0.06% | 0.00% | 34,781 | -70,273 | -66.89% | 115,125 | Jun 30, 2024 |
| SIMPLEX TRADING, LLC | 0.05% | 0.00% | 29,302 | -64,163 | -68.65% | 96,000 | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -61,601 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -47,300 | -100.00% | - | Jun 30, 2024 |
| LOS ANGELES CAPITAL MANAGEMENT LLC | 0.56% | 0.00% | 334,669 | -46,104 | -12.11% | 1,107,754 | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.33% | 0.00% | 193,115 | -45,849 | -19.19% | 639,211 | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -38,193 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.52% | 0.00% | 311,404 | -38,142 | -10.91% | 1,030,748 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -22,952 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.01% | - | 4,028 | -21,250 | -84.07% | 13,333 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.64% | 0.00% | 378,490 | -20,461 | -5.13% | 1,252,803 | Jun 30, 2024 |
As of Jun 30 2024, Aldeyra Therapeutics's biggest institutional seller is VERITION FUND MANAGEMENT LLC. The company sold -0.72M shares of ALDX, valued at $727.63K.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| PFG INVESTMENTS, LLC | 0.67% | 0.09% | 396,247 | 396,247 | 100.00% | 1,311,578 | Jun 30, 2024 |
| PANAGORA ASSET MANAGEMENT INC | 0.10% | 0.00% | 60,298 | 60,298 | 100.00% | 199,586 | Jun 30, 2024 |
| CIBC PRIVATE WEALTH GROUP, LLC | 0.09% | 0.00% | 51,458 | 51,458 | 100.00% | 170,326 | Jun 30, 2024 |
| ALPS ADVISORS INC | 0.08% | 0.00% | 46,326 | 46,326 | 100.00% | 153,339 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.05% | 0.00% | 26,802 | 26,802 | 100.00% | 88,715 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 24,405 | 24,405 | 100.00% | 80,781 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.02% | 0.00% | 14,168 | 14,168 | 100.00% | 46,896 | Jun 30, 2024 |
| DIVERSIFIED TRUST CO | 0.02% | 0.00% | 12,265 | 12,265 | 100.00% | 40,597 | Jun 30, 2024 |
| CLEARSTEAD ADVISORS, LLC | 0.02% | 0.00% | 10,398 | 10,398 | 100.00% | 34,418 | Jun 30, 2024 |
| ACTIVEST WEALTH MANAGEMENT | 0.00% | 0.00% | 2,000 | 2,000 | 100.00% | 6,620 | Jun 30, 2024 |
| NVERSES CAPITAL, LLC | 0.00% | 0.00% | 1,700 | 1,700 | 100.00% | 5,627 | Jun 30, 2024 |
| SRS CAPITAL ADVISORS, INC. | 0.00% | 0.00% | 266 | 266 | 100.00% | 881 | Jun 30, 2024 |
| INNEALTA CAPITAL, LLC | 0.00% | 0.00% | 46 | 46 | 100.00% | 152 | Jun 30, 2024 |
| PNC FINANCIAL SERVICES GROUP, INC. | 0.00% | - | 34 | 34 | 100.00% | 113 | Jun 30, 2024 |
Aldeyra Therapeutics's largest new institutional shareholder by number of shares is PFG INVESTMENTS, LLC, purchased 396.25K shares, valued at $1.31M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERIPRISE FINANCIAL INC | - | - | - | -126,176 | -100.00% | - | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | - | - | - | -107,748 | -100.00% | - | Jun 30, 2024 |
| CORNERCAP INVESTMENT COUNSEL INC | - | - | - | -61,601 | -100.00% | - | Jun 30, 2024 |
| DENALI ADVISORS LLC | - | - | - | -47,300 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -38,193 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -22,952 | -100.00% | - | Jun 30, 2024 |
| XTX TOPCO LTD | - | - | - | -19,664 | -100.00% | - | Jun 30, 2024 |
| ALGERT GLOBAL LLC | - | - | - | -15,670 | -100.00% | - | Jun 30, 2024 |
| KINGSWOOD WEALTH ADVISORS, LLC | - | - | - | -15,000 | -100.00% | - | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | - | - | - | -11,356 | -100.00% | - | Jun 30, 2024 |
| WOLVERINE TRADING, LLC | - | - | - | -11,100 | -100.00% | - | Jun 30, 2024 |
| LINDBROOK CAPITAL, LLC | - | - | - | -544 | -100.00% | - | Jun 30, 2024 |
| TRUVESTMENTS CAPITAL LLC | - | - | - | -265 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -197 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -9 | -100.00% | - | Jun 30, 2024 |
Aldeyra Therapeutics's largest sold out institutional shareholder by shares sold is AMERIPRISE FINANCIAL INC, sold -0.13M shares, valued at -, as of undefined.
Aldeyra Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| VANGUARD VALLEY FORGE FUNDS | 0.07% | 34,700 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.06% | 753,477 | 618,037 | 456.32% | Jan 31, 2024 |
| BNY Mellon Strategic Funds, Inc. | 0.03% | 70,685 | - | - | Mar 31, 2024 |
| FORUM FUNDS II | 0.02% | 20,444 | - | - | Jan 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 146,320 | - | - | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 86,250 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 7,208 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 784,037 | - | - | Feb 29, 2024 |
| Federated Hermes MDT Series | 0.01% | 21,063 | - | - | Jan 31, 2024 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 25,103 | - | - | Feb 29, 2024 |
| Nushares ETF Trust | 0.01% | 57,215 | - | - | Jan 31, 2024 |
| Weiss Strategic Interval Fund | 0.01% | 22,580 | 22,580 | - | Sep 30, 2022 |
| ETFis Series Trust I | 0.01% | 9,460 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,493,755 | -673,037 | -21.25% | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.01% | 1,235 | - | - | Mar 31, 2024 |
| CARILLON SERIES TRUST | 0.01% | 283,577 | -13,479 | -4.54% | Mar 31, 2024 |
| Columbia Funds Variable Series Trust II | 0.00% | 156,558 | - | - | Mar 31, 2024 |
| VANGUARD HORIZON FUNDS | 0.00% | 82,817 | -253,299 | -75.36% | Mar 31, 2024 |
| ALPS ETF Trust | 0.00% | 41,392 | - | - | Feb 29, 2024 |
| Ultimus Managers Trust | 0.00% | 37,257 | - | - | Feb 29, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 125,525 | - | - | Jan 31, 2024 |
| VICTORY PORTFOLIOS | 0.00% | 70,660 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 451,736 | 31,927 | 7.61% | Feb 29, 2024 |
| NEW COVENANT FUNDS | 0.00% | 9,277 | - | - | Dec 31, 2023 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.00% | 172,465 | - | - | Jan 31, 2024 |
| BMO FUNDS, INC. | 0.00% | 77,085 | - | - | Nov 30, 2021 |
| PFM Multi-Manager Series Trust | 0.00% | 1,524 | - | - | Dec 31, 2023 |
| CALAMOS INVESTMENT TRUST/IL | 0.00% | 179,019 | - | - | Jan 31, 2024 |
| GOLDMAN SACHS VARIABLE INSURANCE TRUST | 0.00% | 6,537 | - | - | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 3,846 | - | - | Mar 31, 2024 |
| Direxion Shares ETF Trust | 0.00% | 210,963 | - | - | Jan 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 24,412 | - | - | Jan 31, 2024 |
| Managed Portfolio Series | 0.00% | 27,962 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 36,996 | -2,704 | -6.81% | Mar 31, 2024 |
| Fidelity Commonwealth Trust II | 0.00% | 7,615 | - | - | Aug 31, 2023 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 53,009 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 1,012,885 | 343,923 | 51.41% | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 3,223 | - | - | Mar 28, 2024 |
| VANGUARD WORLD FUND | 0.00% | 159,559 | 816 | 0.51% | Feb 29, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 6,718 | - | - | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 2,558 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 16,086 | -3,248 | -16.80% | Mar 31, 2024 |
| ADVISORS' INNER CIRCLE FUND | 0.00% | 11,563 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 10,567 | 405 | 3.99% | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 191 | - | - | Apr 30, 2021 |
| GPS Funds I | 0.00% | 1,798 | - | - | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.00% | 2,832 | 2,832 | - | Mar 28, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 717 | - | - | Mar 31, 2024 |
| Dimensional ETF Trust | 0.00% | 114,528 | -140,915 | -55.16% | Jan 31, 2024 |
| Series Portfolios Trust | 0.00% | 1,589 | - | - | Jan 31, 2024 |
| SA FUNDS INVESTMENT TRUST | 0.00% | 3,971 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 14,300 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 1,043 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 2,374 | - | - | Mar 31, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 16,860 | 5,682 | 50.83% | Feb 29, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 18,829 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 8,641 | - | - | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 17,712 | -3,729 | -17.39% | Mar 28, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 1,127 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 135,183 | - | - | Mar 31, 2024 |
| HC CAPITAL TRUST | 0.00% | 3,496 | - | - | Mar 31, 2024 |
| iSHARES TRUST | 0.00% | 1,776,318 | -95,555 | -5.10% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 210,599 | 25,791 | 13.96% | Feb 29, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 22,665 | - | - | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 425 | - | - | Dec 31, 2023 |
| VANGUARD WELLINGTON FUND | 0.00% | 41,019 | - | - | Feb 29, 2024 |
| Columbia Funds Series Trust II | 0.00% | 37,350 | - | - | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 10,691 | -17,739 | -62.40% | Mar 28, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 8,921 | - | - | Feb 29, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 4,660 | - | - | Dec 31, 2023 |
| Blackstone Alternative Investment Funds | 0.00% | 9,800 | - | - | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 25,797 | - | - | Jan 31, 2024 |
| THRIVENT MUTUAL FUNDS | 0.00% | 6,343 | -10,517 | -62.38% | Jan 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 8,386 | -54 | -0.64% | Jan 31, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,800 | - | - | Mar 28, 2024 |
| VALIC Co I | 0.00% | 17,873 | -72 | -0.40% | Feb 29, 2024 |
| SPDR SERIES TRUST | 0.00% | 2,156,928 | - | - | Mar 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 211 | - | - | Dec 31, 2023 |
| Guggenheim Active Allocation Fund | 0.00% | 289 | - | - | Feb 29, 2024 |
| PGIM ETF TRUST | 0.00% | 2,927 | - | - | Feb 29, 2024 |
| Pacer Funds Trust | 0.00% | 1,903 | - | - | Jan 31, 2024 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 11,962 | -309,661 | -96.28% | Feb 29, 2024 |
| TIAA-CREF FUNDS | 0.00% | 103,374 | - | - | Jan 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 7,560 | 1,314 | 21.04% | Jan 31, 2024 |
| ETF Series Solutions | 0.00% | 674 | - | - | Jan 31, 2024 |
| ProFunds | 0.00% | 362 | -30 | -7.65% | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 6,824 | 814 | 13.54% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 28 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 23,019 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 59,024 | -29,229 | -33.12% | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 48,794 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 15,823 | 125 | 0.80% | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,677 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 5,276 | -6,232 | -54.15% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 843 | - | - | Feb 29, 2024 |
| SPDR INDEX SHARES FUNDS | 0.00% | 2,125 | - | - | Mar 31, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 18,921 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 179,670 | 170,470 | 1852.93% | Feb 29, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 1,990 | - | - | Dec 31, 2023 |
| FIDELITY SALEM STREET TRUST | 0.00% | 22,878 | 2,635 | 13.02% | Mar 31, 2024 |
Aldeyra Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 34.70K shares, compromising 0.07% of its total assets.
Aldeyra Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 104 | -1.89% |
| 31 Mar, 24 | 106 | -2.75% |
| 31 Dec, 23 | 109 | -13.49% |
| 30 Sep, 23 | 126 | -4.55% |
| 30 Jun, 23 | 132 | 11.86% |
| 31 Mar, 23 | 118 | 15.69% |
| 31 Dec, 22 | 102 | 7.37% |
| 30 Sep, 22 | 95 | -2.06% |
| 30 Jun, 22 | 97 | -14.91% |
| 31 Mar, 22 | 114 | -13.64% |
| 31 Dec, 21 | 132 | - |
| 30 Sep, 21 | 132 | -7.69% |
| 30 Jun, 21 | 143 | 24.35% |
| 31 Mar, 21 | 115 | 15.00% |
| 31 Dec, 20 | 100 | 16.28% |
| 30 Sep, 20 | 86 | 2.38% |
| 30 Jun, 20 | 84 | 18.31% |
| 31 Mar, 20 | 71 | -10.13% |
| 31 Dec, 19 | 79 | 9.72% |
| 30 Sep, 19 | 72 | -7.69% |
| 30 Jun, 19 | 78 | -9.30% |
| 31 Mar, 19 | 86 | 11.69% |
| 31 Dec, 18 | 77 | -20.62% |
| 30 Sep, 18 | 97 | 46.97% |
| 30 Jun, 18 | 66 | 50.00% |
| 31 Mar, 18 | 44 | 22.22% |
| 31 Dec, 17 | 36 | 2.86% |
| 30 Sep, 17 | 35 | 45.83% |
| 30 Jun, 17 | 24 | - |
| 31 Mar, 17 | 24 | 20.00% |
| 31 Dec, 16 | 20 | -9.09% |
| 30 Sep, 16 | 22 | -15.38% |
| 30 Jun, 16 | 26 | -3.70% |
| 31 Mar, 16 | 27 | 35.00% |
| 31 Dec, 15 | 20 | -9.09% |
| 30 Sep, 15 | 22 | -4.35% |
| 30 Jun, 15 | 23 | 53.33% |
| 31 Mar, 15 | 15 | 200.00% |
| 31 Dec, 14 | 5 | -16.67% |
| 30 Sep, 14 | 6 | 20.00% |
| 30 Jun, 14 | 5 | - |
As of 30 Jun 24, 104 institutions are holding Aldeyra Therapeutics's shares, representing a decrease of -1.89% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 35,133,134 | -0.81% |
| 31 Mar, 24 | 35,421,654 | 0.85% |
| 31 Dec, 23 | 35,123,488 | -7.02% |
| 30 Sep, 23 | 37,775,100 | -3.23% |
| 30 Jun, 23 | 39,037,783 | 9.70% |
| 31 Mar, 23 | 35,585,920 | 4.10% |
| 31 Dec, 22 | 34,183,774 | -7.53% |
| 30 Sep, 22 | 36,967,362 | 0.05% |
| 30 Jun, 22 | 36,950,691 | -4.37% |
| 31 Mar, 22 | 38,637,945 | 5.86% |
| 31 Dec, 21 | 36,499,223 | -8.07% |
| 30 Sep, 21 | 39,703,260 | -12.28% |
| 30 Jun, 21 | 45,260,136 | 43.05% |
| 31 Mar, 21 | 31,638,937 | 41.78% |
| 31 Dec, 20 | 22,314,812 | -6.01% |
| 30 Sep, 20 | 23,741,755 | 62.68% |
| 30 Jun, 20 | 14,593,924 | -12.98% |
| 31 Mar, 20 | 16,769,883 | -5.29% |
| 31 Dec, 19 | 17,705,656 | 4.98% |
| 30 Sep, 19 | 16,865,553 | -0.14% |
| 30 Jun, 19 | 16,888,841 | 3.22% |
| 31 Mar, 19 | 16,361,446 | -4.64% |
| 31 Dec, 18 | 17,158,166 | -3.86% |
| 30 Sep, 18 | 17,846,574 | 47.11% |
| 30 Jun, 18 | 12,131,707 | 17.95% |
| 31 Mar, 18 | 10,285,558 | 5.19% |
| 31 Dec, 17 | 9,778,234 | 6.04% |
| 30 Sep, 17 | 9,221,617 | 23.99% |
| 30 Jun, 17 | 7,437,289 | -5.83% |
| 31 Mar, 17 | 7,897,813 | 28.70% |
| 31 Dec, 16 | 6,136,618 | 0.39% |
| 30 Sep, 16 | 6,112,780 | -3.87% |
| 30 Jun, 16 | 6,358,904 | 45.41% |
| 31 Mar, 16 | 4,372,967 | -1.24% |
| 31 Dec, 15 | 4,427,755 | -50.72% |
| 30 Sep, 15 | 8,985,304 | 112.64% |
| 30 Jun, 15 | 4,225,512 | 149.77% |
| 31 Mar, 15 | 1,691,795 | 94.43% |
| 31 Dec, 14 | 870,138 | 1.26% |
| 30 Sep, 14 | 859,337 | 0.86% |
| 30 Jun, 14 | 852,047 | - |
Aldeyra Therapeutics (ALDX) has 35.13M shares outstanding as of 30 Jun 24, down -0.81% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 59.13% | 1.64% |
| 31 Mar, 24 | 60.09% | 1.70% |
| 31 Dec, 23 | 59.54% | 1.44% |
| 30 Sep, 23 | 64.25% | 1.46% |
| 30 Jun, 23 | 66.40% | 1.81% |
| 31 Mar, 23 | 60.53% | 1.77% |
| 31 Dec, 22 | 58.53% | 1.46% |
| 30 Sep, 22 | 63.24% | 1.57% |
| 30 Jun, 22 | 63.38% | 1.44% |
| 31 Mar, 22 | 66.28% | 1.67% |
| 31 Dec, 21 | 62.91% | 1.34% |
| 30 Sep, 21 | 68.43% | 0.98% |
| 30 Jun, 21 | 83.38% | 1.73% |
| 31 Mar, 21 | 69.34% | 1.61% |
| 31 Dec, 20 | 65.70% | 1.67% |
| 30 Sep, 20 | 62.81% | 2.68% |
| 30 Jun, 20 | 48.46% | 1.47% |
| 31 Mar, 20 | 57.41% | 1.56% |
| 31 Dec, 19 | 60.61% | 1.57% |
| 30 Sep, 19 | 62.21% | 1.59% |
| 30 Jun, 19 | 62.59% | 1.71% |
| 31 Mar, 19 | 60.48% | 0.97% |
| 31 Dec, 18 | 79.12% | 1.09% |
| 30 Sep, 18 | 85.11% | 2.26% |
| 30 Jun, 18 | 61.39% | 2.18% |
| 31 Mar, 18 | 53.11% | 1.41% |
| 31 Dec, 17 | 61.41% | 1.75% |
| 30 Sep, 17 | 59.18% | 2.45% |
| 30 Jun, 17 | 49.14% | 1.50% |
| 31 Mar, 17 | 57.24% | 2.89% |
| 31 Dec, 16 | 44.48% | 1.85% |
| 30 Sep, 16 | 49.00% | 1.37% |
| 30 Jun, 16 | 59.86% | 2.95% |
| 31 Mar, 16 | 45.02% | 1.71% |
| 31 Dec, 15 | 51.28% | 0.60% |
| 30 Sep, 15 | 92.51% | 3.65% |
| 30 Jun, 15 | 50.32% | 7.82% |
| 31 Mar, 15 | 25.37% | 14.90% |
| 31 Dec, 14 | 13.05% | 5.47% |
| 30 Sep, 14 | 15.44% | 2.97% |
| 30 Jun, 14 | 22.80% | - |
As of 30 Jun 24, Aldeyra Therapeutics is held by 59.13% institutional shareholders, representing a 1.64% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 51 | 10.87% |
| 31 Mar, 24 | 46 | - |
| 31 Dec, 23 | 46 | -13.21% |
| 30 Sep, 23 | 53 | -28.38% |
| 30 Jun, 23 | 74 | 25.42% |
| 31 Mar, 23 | 59 | 31.11% |
| 31 Dec, 22 | 45 | 21.62% |
| 30 Sep, 22 | 37 | -11.90% |
| 30 Jun, 22 | 42 | -16.00% |
| 31 Mar, 22 | 50 | -18.03% |
| 31 Dec, 21 | 61 | 38.64% |
| 30 Sep, 21 | 44 | -54.17% |
| 30 Jun, 21 | 96 | 47.69% |
| 31 Mar, 21 | 65 | 32.65% |
| 31 Dec, 20 | 49 | -5.77% |
| 30 Sep, 20 | 52 | 10.64% |
| 30 Jun, 20 | 47 | 62.07% |
| 31 Mar, 20 | 29 | -40.82% |
| 31 Dec, 19 | 49 | 48.48% |
| 30 Sep, 19 | 33 | -26.67% |
| 30 Jun, 19 | 45 | -11.76% |
| 31 Mar, 19 | 51 | 13.33% |
| 31 Dec, 18 | 45 | -28.57% |
| 30 Sep, 18 | 63 | 34.04% |
| 30 Jun, 18 | 47 | 62.07% |
| 31 Mar, 18 | 29 | 38.10% |
| 31 Dec, 17 | 21 | -25.00% |
| 30 Sep, 17 | 28 | 100.00% |
| 30 Jun, 17 | 14 | -12.50% |
| 31 Mar, 17 | 16 | 166.67% |
| 31 Dec, 16 | 6 | -25.00% |
| 30 Sep, 16 | 8 | -52.94% |
| 30 Jun, 16 | 17 | 54.55% |
| 31 Mar, 16 | 11 | 266.67% |
| 31 Dec, 15 | 3 | -66.67% |
| 30 Sep, 15 | 9 | -47.06% |
| 30 Jun, 15 | 17 | 41.67% |
| 31 Mar, 15 | 12 | 500.00% |
| 31 Dec, 14 | 2 | -33.33% |
| 30 Sep, 14 | 3 | -40.00% |
| 30 Jun, 14 | 5 | - |
51 institutional shareholders have increased their position in ALDX stock as of 30 Jun 24 compared to 46 in the previous quarter (a 10.87% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 31 | -6.06% |
| 31 Mar, 24 | 33 | -28.26% |
| 31 Dec, 23 | 46 | 15.00% |
| 30 Sep, 23 | 40 | 42.86% |
| 30 Jun, 23 | 28 | 7.69% |
| 31 Mar, 23 | 26 | -25.71% |
| 31 Dec, 22 | 35 | 9.38% |
| 30 Sep, 22 | 32 | 3.23% |
| 30 Jun, 22 | 31 | -16.22% |
| 31 Mar, 22 | 37 | - |
| 31 Dec, 21 | 37 | -21.28% |
| 30 Sep, 21 | 47 | 88.00% |
| 30 Jun, 21 | 25 | 8.70% |
| 31 Mar, 21 | 23 | -11.54% |
| 31 Dec, 20 | 26 | 30.00% |
| 30 Sep, 20 | 20 | -23.08% |
| 30 Jun, 20 | 26 | 4.00% |
| 31 Mar, 20 | 25 | 38.89% |
| 31 Dec, 19 | 18 | -10.00% |
| 30 Sep, 19 | 20 | 17.65% |
| 30 Jun, 19 | 17 | -10.53% |
| 31 Mar, 19 | 19 | 5.56% |
| 31 Dec, 18 | 18 | 28.57% |
| 30 Sep, 18 | 14 | 180.00% |
| 30 Jun, 18 | 5 | 25.00% |
| 31 Mar, 18 | 4 | -50.00% |
| 31 Dec, 17 | 8 | 60.00% |
| 30 Sep, 17 | 5 | -16.67% |
| 30 Jun, 17 | 6 | 50.00% |
| 31 Mar, 17 | 4 | 33.33% |
| 31 Dec, 16 | 3 | - |
| 30 Sep, 16 | 3 | -25.00% |
| 30 Jun, 16 | 4 | -20.00% |
| 31 Mar, 16 | 5 | -16.67% |
| 31 Dec, 15 | 6 | 50.00% |
| 30 Sep, 15 | 4 | 100.00% |
| 30 Jun, 15 | 2 | - |
| 31 Mar, 15 | - | - |
| 31 Dec, 14 | - | -100.00% |
| 30 Sep, 14 | 1 | - |
| 30 Jun, 14 | - | - |
31 institutional shareholders have reduced their position in ALDX stock as of 30 Jun 24 compared to 33 in the previous quarter (a -6.06% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 104 | -1.89% | 35,133,134 | -0.81% | 59.13% | 1.64% | 51 | 10.87% | 31 | -6.06% |
| 31 Mar, 24 | 106 | -2.75% | 35,421,654 | 0.85% | 60.09% | 1.70% | 46 | - | 33 | -28.26% |
| 31 Dec, 23 | 109 | -13.49% | 35,123,488 | -7.02% | 59.54% | 1.44% | 46 | -13.21% | 46 | 15.00% |
| 30 Sep, 23 | 126 | -4.55% | 37,775,100 | -3.23% | 64.25% | 1.46% | 53 | -28.38% | 40 | 42.86% |
| 30 Jun, 23 | 132 | 11.86% | 39,037,783 | 9.70% | 66.40% | 1.81% | 74 | 25.42% | 28 | 7.69% |
| 31 Mar, 23 | 118 | 15.69% | 35,585,920 | 4.10% | 60.53% | 1.77% | 59 | 31.11% | 26 | -25.71% |
| 31 Dec, 22 | 102 | 7.37% | 34,183,774 | -7.53% | 58.53% | 1.46% | 45 | 21.62% | 35 | 9.38% |
| 30 Sep, 22 | 95 | -2.06% | 36,967,362 | 0.05% | 63.24% | 1.57% | 37 | -11.90% | 32 | 3.23% |
| 30 Jun, 22 | 97 | -14.91% | 36,950,691 | -4.37% | 63.38% | 1.44% | 42 | -16.00% | 31 | -16.22% |
| 31 Mar, 22 | 114 | -13.64% | 38,637,945 | 5.86% | 66.28% | 1.67% | 50 | -18.03% | 37 | - |
| 31 Dec, 21 | 132 | - | 36,499,223 | -8.07% | 62.91% | 1.34% | 61 | 38.64% | 37 | -21.28% |
| 30 Sep, 21 | 132 | -7.69% | 39,703,260 | -12.28% | 68.43% | 0.98% | 44 | -54.17% | 47 | 88.00% |
| 30 Jun, 21 | 143 | 24.35% | 45,260,136 | 43.05% | 83.38% | 1.73% | 96 | 47.69% | 25 | 8.70% |
| 31 Mar, 21 | 115 | 15.00% | 31,638,937 | 41.78% | 69.34% | 1.61% | 65 | 32.65% | 23 | -11.54% |
| 31 Dec, 20 | 100 | 16.28% | 22,314,812 | -6.01% | 65.70% | 1.67% | 49 | -5.77% | 26 | 30.00% |
| 30 Sep, 20 | 86 | 2.38% | 23,741,755 | 62.68% | 62.81% | 2.68% | 52 | 10.64% | 20 | -23.08% |
| 30 Jun, 20 | 84 | 18.31% | 14,593,924 | -12.98% | 48.46% | 1.47% | 47 | 62.07% | 26 | 4.00% |
| 31 Mar, 20 | 71 | -10.13% | 16,769,883 | -5.29% | 57.41% | 1.56% | 29 | -40.82% | 25 | 38.89% |
| 31 Dec, 19 | 79 | 9.72% | 17,705,656 | 4.98% | 60.61% | 1.57% | 49 | 48.48% | 18 | -10.00% |
| 30 Sep, 19 | 72 | -7.69% | 16,865,553 | -0.14% | 62.21% | 1.59% | 33 | -26.67% | 20 | 17.65% |
| 30 Jun, 19 | 78 | -9.30% | 16,888,841 | 3.22% | 62.59% | 1.71% | 45 | -11.76% | 17 | -10.53% |
| 31 Mar, 19 | 86 | 11.69% | 16,361,446 | -4.64% | 60.48% | 0.97% | 51 | 13.33% | 19 | 5.56% |
| 31 Dec, 18 | 77 | -20.62% | 17,158,166 | -3.86% | 79.12% | 1.09% | 45 | -28.57% | 18 | 28.57% |
| 30 Sep, 18 | 97 | 46.97% | 17,846,574 | 47.11% | 85.11% | 2.26% | 63 | 34.04% | 14 | 180.00% |
| 30 Jun, 18 | 66 | 50.00% | 12,131,707 | 17.95% | 61.39% | 2.18% | 47 | 62.07% | 5 | 25.00% |
| 31 Mar, 18 | 44 | 22.22% | 10,285,558 | 5.19% | 53.11% | 1.41% | 29 | 38.10% | 4 | -50.00% |
| 31 Dec, 17 | 36 | 2.86% | 9,778,234 | 6.04% | 61.41% | 1.75% | 21 | -25.00% | 8 | 60.00% |
| 30 Sep, 17 | 35 | 45.83% | 9,221,617 | 23.99% | 59.18% | 2.45% | 28 | 100.00% | 5 | -16.67% |
| 30 Jun, 17 | 24 | - | 7,437,289 | -5.83% | 49.14% | 1.50% | 14 | -12.50% | 6 | 50.00% |
| 31 Mar, 17 | 24 | 20.00% | 7,897,813 | 28.70% | 57.24% | 2.89% | 16 | 166.67% | 4 | 33.33% |
| 31 Dec, 16 | 20 | -9.09% | 6,136,618 | 0.39% | 44.48% | 1.85% | 6 | -25.00% | 3 | - |
| 30 Sep, 16 | 22 | -15.38% | 6,112,780 | -3.87% | 49.00% | 1.37% | 8 | -52.94% | 3 | -25.00% |
| 30 Jun, 16 | 26 | -3.70% | 6,358,904 | 45.41% | 59.86% | 2.95% | 17 | 54.55% | 4 | -20.00% |
| 31 Mar, 16 | 27 | 35.00% | 4,372,967 | -1.24% | 45.02% | 1.71% | 11 | 266.67% | 5 | -16.67% |
| 31 Dec, 15 | 20 | -9.09% | 4,427,755 | -50.72% | 51.28% | 0.60% | 3 | -66.67% | 6 | 50.00% |
| 30 Sep, 15 | 22 | -4.35% | 8,985,304 | 112.64% | 92.51% | 3.65% | 9 | -47.06% | 4 | 100.00% |
| 30 Jun, 15 | 23 | 53.33% | 4,225,512 | 149.77% | 50.32% | 7.82% | 17 | 41.67% | 2 | - |
| 31 Mar, 15 | 15 | 200.00% | 1,691,795 | 94.43% | 25.37% | 14.90% | 12 | 500.00% | - | - |
| 31 Dec, 14 | 5 | -16.67% | 870,138 | 1.26% | 13.05% | 5.47% | 2 | -33.33% | - | -100.00% |
| 30 Sep, 14 | 6 | 20.00% | 859,337 | 0.86% | 15.44% | 2.97% | 3 | -40.00% | 1 | - |
| 30 Jun, 14 | 5 | - | 852,047 | - | 22.80% | - | 5 | - | - | - |
Aldeyra Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
| Date | Name | Relation | Role | Transaction | Buy/Sell | Shares | Price | Value | Shares Held | Source |
|---|
Insider Sells
All Insider Owners Trades
The last insider sell of Aldeyra Therapeutics's stock was made by Machatha Stephen on Aug 14 2024, selling 16,041 shares at $4.74 per share (valued at $75.97K).
Aldeyra Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 2 | - |
| Q2 2024 | 21 | - | - |
| Q1 2024 | 3 | 7 | 42.86% |
| Q4 2023 | - | 2 | - |
| Q3 2023 | 5 | 4 | 125.00% |
| Q2 2023 | 18 | - | - |
| Q1 2023 | 3 | 1 | 300.00% |
| Q3 2022 | 22 | - | - |
| Q2 2022 | 21 | 7 | 300.00% |
| Q1 2022 | 7 | - | - |
| Q2 2021 | 21 | - | - |
| Q1 2021 | 5 | - | - |
| Q4 2020 | - | 6 | - |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 23 | - | - |
| Q1 2020 | 15 | - | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | 19 | - | - |
| Q2 2019 | 19 | - | - |
| Q1 2019 | 8 | 4 | 200.00% |
0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by Aldeyra Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | 2 | - |
| Q2 2024 | 5 | - | - |
| Q1 2024 | - | 7 | - |
| Q4 2023 | - | 2 | - |
| Q3 2023 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | 19 | - | - |
| Q2 2022 | 2 | - | - |
| Q1 2022 | - | - | - |
| Q2 2021 | 1 | - | - |
| Q1 2021 | 5 | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 1 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | 1 | - | - |
| Q4 2019 | 1 | - | - |
| Q3 2019 | 19 | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | - | 4 | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of Aldeyra Therapeutics's stocks.
Aldeyra Therapeutics Peer Ownership
| Ticker | Company |
|---|---|
| LXRX | Lexicon Pharmaceuticals, Inc. |
| XFOR | X4 Pharmaceuticals, Inc. |
| CGEM | Cullinan Oncology, Inc. |
| VRDN | Viridian Therapeutics, Inc. |
| BPMC | Blueprint Medicines Corporation |
| DAWN | Day One Biopharmaceuticals, Inc. |
| PHAT | Phathom Pharmaceuticals, Inc. |
| HOOK | HOOKIPA Pharma Inc. |
| TVTX | Travere Therapeutics, Inc. |
| BLRX | BioLineRx Ltd. |
| MCRB | Seres Therapeutics, Inc. |
| LIAN | LianBio |
| ARDX | Ardelyx, Inc. |
| ETON | Eton Pharmaceuticals, Inc. |
| TERN | Terns Pharmaceuticals, Inc. |
| IBRX | ImmunityBio, Inc. |
| INZY | Inozyme Pharma, Inc. |
| GPCR | Structure Therapeutics Inc. |
| TARS | Tarsus Pharmaceuticals, Inc. |
| ETNB | 89bio, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
ALDX Ownership FAQ
Who Owns Aldeyra Therapeutics?
Aldeyra Therapeutics is owned by institutional shareholders (59.13%), insiders (2.45%), and public (38.42%). The largest institutional shareholder of Aldeyra Therapeutics is PERCEPTIVE ADVISORS LLC (15.61% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (0.07% of total shares).
Who are the major institutional shareholders of Aldeyra Therapeutics?
Aldeyra Therapeutics's major institutional shareholders are PERCEPTIVE ADVISORS LLC, KNOLL CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, BLACKROCK INC., and KENNEDY CAPITAL MANAGEMENT LLC. The top five shareholders own together 39.92% of the company's share outstanding.
How many Aldeyra Therapeutics shareholders are there?
As of Jun 2024, there are 104 institutional shareholders of Aldeyra Therapeutics.
What percentage of Aldeyra Therapeutics is owned by PERCEPTIVE ADVISORS LLC?
PERCEPTIVE ADVISORS LLC owns 9.28M shares of Aldeyra Therapeutics, representing 15.61% of the company's total shares outstanding, valued at $30.7M (as of Jun 2024).
What percentage of Aldeyra Therapeutics is owned by KNOLL CAPITAL MANAGEMENT, LLC?
As of Jun 2024, KNOLL CAPITAL MANAGEMENT, LLC holds 5.48M shares of Aldeyra Therapeutics (ALDX), compromising 9.22% of the company, valued at $18.12M.
What percentage of Aldeyra Therapeutics is owned by VANGUARD GROUP INC?
VANGUARD GROUP INC is the third largest holder of Aldeyra Therapeutics. The company owns 3.74M of the company's shares outstanding (worth $12.39M).